Evidence map›Paper›PMID 37449907›Full record

ReviewBiochemical Society transactions2023

γ-Secretase fanning the fire of innate immunity.

Chenge Liu, Cyrus Nikain, Yue-Ming Li

Open access · greenAbstract readReview
In one paragraph

Review in Biochemical Society transactions, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 68% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chenge Liu *Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A.
Cyrus Nikain *Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A.
Yue-Ming LiChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A.ORCID 0000-0002-2633-3730
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Regulation of y-secretase activity by modulatory proteinsR01AG061350 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI LI, YUEMING · 2019 to 2023
$4.3M
Molecular mechanisms of gamma-secretase modulation central to Alzheimer’s diseaseR01AG080684 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI Liang Feng, YUEMING LI · 2023 to 2026
$3.2M
Substrate Feedback Mechanism of gamma-SecretaseRF1AG057593 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI LI, YUEMING · 2018 to 2018
$2.1M
NCI NIH HHS P30 CA008748NIA NIH HHS R01 AG061350NIA NIH HHS R01 AG080684NIA NIH HHS RF1 AG057593
6 · The paper itself

Abstract

Innate immunity is the first line of defense against pathogens, alerting the individual cell and surrounding area to respond to this potential invasion. γ-secretase is a transmembrane protease complex that plays an intricate role in nearly every stage of this innate immune response. Through regulation of pattern recognition receptors (PRR) such as TREM2 and RAGE γ-secretase can modulate pathogen recognition. γ-secretase can act on cytokine receptors such as IFNαR2 and CSF1R to dampen their signaling capacity. While γ-secretase-mediated regulated intramembrane proteolysis (RIP) can further moderate innate immune responses through downstream signaling pathways. Furthermore, γ-secretase has also been shown to be regulated by the innate immune system through cytokine signaling and γ-secretase modulatory proteins such as IFITM3 and Hif-1α. This review article gives an overview of how γ-secretase is implicated in innate immunity and the maintenance of its responses through potentially positive and negative feedback loops.

Indexed as

Amyloid Precursor Protein SecretasesImmunity, InnateSignal TransductionAmyloid Precursor Protein Secretasescytokine signalingHif1aIFITM3inflammationinnate immunityregulated intramembrane proteolysis

Identifiers

PMID37449907
PMCPMC11212119
OpenAlexW4384343270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.